文献速递牙周病

SETD1与NF-κB通过H3K4三甲基化调控牙周炎症

SETD1 and NF-κB Regulate Periodontal Inflammation through H3K4 Trimethylation.
PubMed 文献 · J Dent Res · 2020-08-07

本研究在牙周膜细胞培养、皮下植入及小鼠牙周炎三种模型中,探讨甲基转移酶SETD1B对炎症基因启动子H3K4三甲基化的调控。结果显示牙龈卟啉单胞菌LPS增加IL-1β、IL-6和MMP2启动子H3K4me3富集,SETD1B抑制可降低该富集及炎症基因表达;NF-κB活化抑制剂BOT-64可减少炎症牙周组织SETD1阳性细胞、恢复组织完整性并促进成骨。

要点

  • 牙周致病菌LPS通过SETD1B增加炎症基因启动子H3K4me3修饰
  • SETD1与p65存在协同作用,共同调控牙周炎症
  • BOT-64抑制NF-κB可减轻牙周炎症及组织破坏

核心结论

  • 组蛋白赖氨酸甲基转移酶SETD1是炎症基因启动子染色质开放的关键因子,通过H3K4三甲基化发挥作用。
  • BOT-64通过抑制NF-κB活性并改善SETD1诱导的染色质松弛,可作为恢复牙周健康的分子治疗药物。

研究设计与样本

  • 实验基于三种模型系统:体外牙周膜细胞培养模型、皮下植入模型和小鼠牙周炎模型。
  • 体外模型使用牙龈卟啉单胞菌LPS作为致病刺激研究SETD1功能与组蛋白甲基化及炎症基因表达的关系。
  • 皮下植入模型通过NF-κB活化抑制剂BOT-64确定SETD1与NF-κB的关系。
  • 小鼠牙周炎模型测试BOT-64是否逆转牙周病相关的炎症组织破坏。

主要发现

  • 在牙周膜祖细胞培养模型中,牙龈卟啉单胞菌LPS增加IL-1β、IL-6和MMP2基因启动子上的H3K4me3组蛋白甲基化。
  • SETD1B抑制降低LPS处理的牙周膜细胞中H3K4me3富集和炎症基因表达。
  • LPS以p65依赖的方式增加SETD1核定位,且p65核转位由SETD1介导,提示SETD1与p65在炎症调控中具有协同效应。
  • 在体内牙周炎症模型中,BOT-64减少炎症牙周组织中SETD1阳性细胞数量,恢复牙周组织完整性并增强成骨。

临床怎么用

  • 靶向SETD1B或NF-κB通路可能成为控制牙周炎症的新策略。
  • BOT-64在动物模型中显示恢复牙周组织完整性和促进成骨的潜力,但尚未应用于临床。

局限性

  • 研究基于体外细胞培养和动物模型,结果尚未在人体中验证。
  • 原文未报告样本量、具体统计值及置信区间等数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The inflammatory response to periodontal pathogens is dynamically controlled by the chromatin state on inflammatory gene promoters. In the present study, we have focused on the effect of the methyltransferase SETD1B on histone H3 lysine K4 (H3K4) histone trimethylation on inflammatory gene promoters. Experiments were based on 3 model systems: 1) an in vitro periodontal ligament (PDL) cell culture model for the study of SETD1 function as it relates to histone methylation and inflammatory gene expression using Porphyromonas gingivalis lipopolysaccharide (LPS) as a pathogen, 2) a subcutaneous implantation model to determine the relationship between SETD1 and nuclear factor κB (NF-κB) through its activation inhibitor BOT-64, and 3) a mouse periodontitis model to test whether the NF-κB activation inhibitor BOT-64 reverses the inflammatory tissue destruction associated with periodontal disease. In our PDL progenitor cell culture model, P. gingivalis LPS increased H3K4me3 histone methylation on IL-1β, IL-6, and MMP2 gene promoters, while SETD1B inhibition decreased H3K4me3 enrichment and inflammatory gene expression in LPS-treated PDL cells. LPS also increased SETD1 nuclear localization in a p65-dependent fashion and the nuclear translocation of p65 as mediated through SETD1, suggestive of a synergistic effect between SETD1 and p65 in the modulation of inflammation. Confirming the role of SETD1 in p65-mediated periodontal inflammation, BOT-64 reduced the number of SETD1-positive cells in inflamed periodontal tissues, restored periodontal tissue integrity, and enhanced osteogenesis in a periodontal inflammation model in vivo. Together, these results have established the histone lysine methyltransferase SETD1 as a key factor in the opening of the chromatin on inflammatory gene promoters through histone H3K4 trimethylation. Our studies also confirmed the role of BOT-64 as a potent molecular therapeutic for the restoration of periodontal health through the inhibition of NF-κB activity and the amelioration of SETD1-induced chromatin relaxation.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Francis M, Gopinathan G, Salapatas A, et al. SETD1 and NF-κB Regulate Periodontal Inflammation through H3K4 Trimethylation. J Dent Res. 2020. PMID: 32762504. doi:10.1177/0022034520939029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。